Comparing Mettler-Toledo International (NYSE:MTD) & Bio-Techne (NASDAQ:TECH)

Mettler-Toledo International (NYSE:MTDGet Free Report) and Bio-Techne (NASDAQ:TECHGet Free Report) are both large-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, valuation, profitability and analyst recommendations.

Valuation & Earnings

This table compares Mettler-Toledo International and Bio-Techne”s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Mettler-Toledo International $4.03 billion 7.10 $869.19 million $44.43 32.09
Bio-Techne $1.21 billion 9.32 $73.40 million $0.69 104.49

Mettler-Toledo International has higher revenue and earnings than Bio-Techne. Mettler-Toledo International is trading at a lower price-to-earnings ratio than Bio-Techne, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

Mettler-Toledo International has a beta of 1.23, suggesting that its stock price is 23% more volatile than the S&P 500. Comparatively, Bio-Techne has a beta of 1.28, suggesting that its stock price is 28% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of current ratings for Mettler-Toledo International and Bio-Techne, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Mettler-Toledo International 0 7 6 0 2.46
Bio-Techne 1 13 3 0 2.12

Mettler-Toledo International presently has a consensus target price of $1,461.27, suggesting a potential upside of 2.49%. Bio-Techne has a consensus target price of $68.08, suggesting a potential downside of 5.58%. Given Mettler-Toledo International’s stronger consensus rating and higher probable upside, research analysts plainly believe Mettler-Toledo International is more favorable than Bio-Techne.

Insider and Institutional Ownership

95.1% of Mettler-Toledo International shares are held by institutional investors. Comparatively, 98.9% of Bio-Techne shares are held by institutional investors. 0.7% of Mettler-Toledo International shares are held by company insiders. Comparatively, 1.3% of Bio-Techne shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Profitability

This table compares Mettler-Toledo International and Bio-Techne’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Mettler-Toledo International 21.91% -1,212.14% 25.11%
Bio-Techne 9.05% 13.57% 10.66%

Summary

Mettler-Toledo International beats Bio-Techne on 8 of the 14 factors compared between the two stocks.

About Mettler-Toledo International

(Get Free Report)

Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments. Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection equipment, x-ray systems, check weighing equipment, camera-based imaging equipment, track-and-trace solutions, and product inspection systems. The company’s retail weighing solutions consist of weighing and software solutions, AI-driven image recognition solution, and automated packaging and labelling solutions for the meat backroom. It serves the life science industry, independent research organizations, and testing labs; food and beverage manufacturers; food retailers; chemical, specialty chemical, and cosmetics companies; food retailers; transportation and logistics, metals, and electronics industries; and the academic community through its direct sales force and indirect distribution channels. Mettler-Toledo International Inc. was incorporated in 1991 and is based in Columbus, Ohio.

About Bio-Techne

(Get Free Report)

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets in the United States, the United Kingdom, rest of Europe, Middle East, and Africa, Greater China, rest of Asia-Pacific, and internationally. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.